Android app Apple app link

Cero announces two granted U.S. patents, European patent application allowance

By Yahoo! Finance   |   3 weeks ago
Cero announces two granted U.S. patents, European patent application allowance

CERo Therapeutics (CERO) Holdings has expanded its intellectual property portfolio with granted U.S. and European patents for chimeric receptors and cellular immunotherapy compositions, enhancing protection for their lead compound CER-1236.

Read More

Did you find this insightful?

Exclusive Content

Access to this content is reserved for premium members. Unlock all features by upgrading to a premium membership.

Get the App

To join as a premium member, please download our app and complete your membership purchase there.